REPLICATION-COMPETENT ADENOVIRUS TYPE 4 SARS-COV-2 VACCINES AND THEIR USE
Technology
E-055-2021
Patent ID
E-055-2021-0-IN-01
Country
IN
Application Type
National Stage
Patent Status
Pending
Patent Number
Publication Number
202317048886A
Application Number
202317048886
IC
NIAID
Date Filed
Date Issued
Patent PDF